Friedreich's ataxia diagnostic study of choice

Jump to navigation Jump to search


Friedreich's ataxia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Friedreich's ataxia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Friedreich's ataxia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Friedreich's ataxia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Friedreich's ataxia diagnostic study of choice

CDC on Friedreich's ataxia diagnostic study of choice

Friedreich's ataxia diagnostic study of choice in the news

Blogs on Friedreich's ataxia diagnostic study of choice

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Friedreich's ataxia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Triplet Repeat Primed PCR (TP PCR) is the gold standard test for the diagnosis of Friedreich’s Ataxia. The following finding on performing genetic testing is confirmatory for Friedreich’s Ataxia: GAA trinucleotide repeat in the first intron of the frataxin gene on chromosome 9q13. The TP PCR must be performed when: The patient presented with symptoms of Friedreich’s Ataxia. History of neuromuscular disorders in a family because the Friedreich’s Ataxia is an autosomal recessive disease and some heterozygous traits may be asymptomatic.

Diagnostic Study of Choice

Study of choice

Triplet Repeat Primed PCR (TP PCR) is the gold standard test for the diagnosis of Friedreich’s Ataxia.

Diagnostic results

The following finding on performing genetic testing is confirmatory for Friedreich’s Ataxia:

Sequence of Diagnostic Studies

The TP PCR must be performed when:

References

Template:WH Template:WS